SCHEMBL3816173

SCHEMBL3816173

COc1ccc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)[C@@H]1CCN(C#N)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
F10 P00742 1/20 0.43
CTSL P07711 1/20 0.42
CTSB P07858 1/20 0.42
CTSS P25774 1/20 0.42
CTSK P43235 1/20 0.42
CTSC P53634 1/20 0.42
RAB9A P51151 2/20 0.41
EP300 Q09472 1/20 0.41
HIF1A Q16665 1/20 0.41
PSEN1 P49768 5/20 0.40
PSEN2 P49810 5/20 0.40
APH1B Q8WW43 5/20 0.40
NCSTN Q92542 5/20 0.40
APH1A Q96BI3 5/20 0.40
PSENEN Q9NZ42 5/20 0.40
USP30 Q70CQ3 2/20 0.40
ALDH1A1 P00352 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3815645 0.92 TSHR (0.44) LMNAMAPTTSHRF10CTSL
SCHEMBL3811330 0.91 CTSL (0.42) LMNAMAPTTSHRF10CTSL
SCHEMBL3810642 0.91 F10 (0.43) LMNAMAPTTSHRF10CTSL
SCHEMBL3810220 0.91 USP30 (0.42) LMNAMAPTTSHRF10CTSL
SCHEMBL3815974 0.90 F10 (0.44) LMNATSHRF10CTSLCTSB
SCHEMBL3811496 0.90 CTSL (0.54) LMNATSHRF10CTSLCTSB
SCHEMBL3814085 0.90 PSEN1 (0.45) LMNAMAPTTSHRF10CTSL
SCHEMBL3808649 0.89 CTSL (0.42) TSHRCTSLCTSBCTSSCTSK
SCHEMBL3811448 0.89 RORC (0.46) LMNAMAPTTSHRCTSLCTSB
SCHEMBL3806371 0.88 CTSL (0.45) TSHRF10CTSLCTSBCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264498-A1 Cathepsin C Inhibitors GLAXO GROUP LIMITED (GB) 2009-10-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264498-A1 Cathepsin C Inhibitors CTSF, CTSZ, CTSG LMNA 1301/4885MAPT 3539/4885TSHR 4126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.